Literature DB >> 11815680

Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures.

K Wada1, N Yamada, T Sato, H Suzuki, M Miki, Y Lee, K Akiyama, S Kuroda.   

Abstract

The authors investigated long-term outcome and treatment strategy of corticosteroid-induced psychotic and mood disorders as defined by DSM-IV. Review of medical records of 2,069 referral patients revealed 18 applicable patients. Their clinical characteristics, longitudinal courses, and treatments were studied. The authors identified 15 patients with mood disorder and 3 patients with psychotic disorder. Increasing doses or resumption of corticosteroids had the strongest influence on the psychiatric course. These two corticosteroid-induced psychiatric disorders may have different pathophysiological substrates closely related to patient vulnerability. Effective psychopharmacological treatment options were indicated with consideration being given to the underlying diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11815680     DOI: 10.1176/appi.psy.42.6.461

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  23 in total

Review 1.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 2.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

3.  Exogenous glucocorticoids decrease subgenual cingulate activity evoked by sadness.

Authors:  Keith D Sudheimer; James L Abelson; Stephan F Taylor; Brian Martis; Robert C Welsh; Christine Warner; Mira Samet; Andrea Manduzzi; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2012-12-03       Impact factor: 7.853

Review 4.  Steroid psychosis: a review for neurosurgeons.

Authors:  Donald A Ross; Justin S Cetas
Journal:  J Neurooncol       Date:  2012-07-05       Impact factor: 4.130

Review 5.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

6.  Glucocorticoids: complications to anticipate and prevent.

Authors:  Lianne S Gensler
Journal:  Neurohospitalist       Date:  2013-04

Review 7.  Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature.

Authors:  Lijun Liu; Shengyun Liu; Wenjuan Guan; Lei Zhang
Journal:  Rheumatol Int       Date:  2016-06-03       Impact factor: 2.631

Review 8.  Mania in the medically ill.

Authors:  Monica Arora; Joan Daughton
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

9.  High Prevalence of Depressive Symptoms Among Ugandan Patients with Rheumatoid Arthritis.

Authors:  Felix Bongomin; Barbra Natukunda; Maria Sekimpi; Ronald Olum; Joseph Baruch Baluku; Anthony Makhoba; Mark Kaddumukasa
Journal:  Open Access Rheumatol       Date:  2021-05-04

10.  Stable Bipolar Patient Switched to Mania following Clinical Doses of Prednisone.

Authors:  Vikram Panwar; Krishan Lassi
Journal:  Case Rep Psychiatry       Date:  2011-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.